United Therapeutics Corp (UTHR) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for UTHR. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 276 institutions reported holding UTHR, with 19.4 million shares worth $10.5 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 5,575,162 | $3.0B | INCREASED |
| Vanguard | 2,183,114 | $1.2B | DECREASED |
| State Street | 1,952,557 | $1.1B | INCREASED |
| Amundi | 988,820 | $536M | NEW |
| Geode Capital Management | 974,993 | $527M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Martine A Rothblatt (Chairperson & CEO) | EXERCISE | 9,500 | $1M | 2026-11-13 |
| Martine A Rothblatt (Chairperson & CEO) | SELL | 40 | $24K | 2026-11-13 |
| Martine A Rothblatt (Chairperson & CEO) | SELL | 440 | $263K | 2026-11-13 |
| Martine A Rothblatt (Chairperson & CEO) | SELL | 480 | $286K | 2026-11-13 |
| Martine A Rothblatt (Chairperson & CEO) | SELL | 1,040 | $619K | 2026-11-13 |
Full institutional holdings, insider history, and congressional trades for United Therapeutics Corp on SentiSense.